Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420803 · ClinicalTrials.gov registry record · NA
A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness
A NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07420803: Recruiting NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, sponsored by Mayo Clinic.
NCT07420803 is a NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420803, a NA study of Chronic Dizziness and Persistent Postural Perceptual Dizziness, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with aurical transcutaneous vagus nerve stimulation (aTVNS).
Primary Outcome
The Dizziness Handicap Inventory (DHI) is a 25-item questionnaire assesses physical, emotional, and functional aspects of dizziness. Each of the 25 questions has three answers: "Always" (4 points), "Sometimes" (2 points), or "No" (0 points). Scores are summed for a total from 0 (no disability) to 100 (maximum disability).
Conditions Studied
Interventions
- OTHER Sham Device
- OTHER Auricular transcutaneous vagus nerve stimulation
Study Locations (1)
Florida
- Mayo Clinic in Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT07420803 shows while recruiting
NCT07420803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Chronic Dizziness appearing as the primary indexed condition, and to 2 interventions - of which Sham Device is the first listed.
NCT07420803 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07420803 about?
NCT07420803 is a clinical study titled "A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness". The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with aurical transcutaneous vagus nerve stimulation (aTVNS).
What is the current status of trial NCT07420803?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-03. Estimated completion is 2027-03.
What conditions does trial NCT07420803 study?
This clinical trial studies the following conditions: Chronic Dizziness, Persistent Postural Perceptual Dizziness.
What interventions are being tested in trial NCT07420803?
The interventions under investigation include: Sham Device (OTHER), Auricular transcutaneous vagus nerve stimulation (OTHER).
Who is sponsoring clinical trial NCT07420803?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420803 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07420803's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia